Crowdfunding launch for cystic fibrosis drug developer

The equity crowdfunding run in New Zealand is gathering steam, with yet another company launching a campaign today. This time it is a local drug developer, which may have a treatment for cystic fibrosis sufferers.

Breathe Easy Therapeutics, an Auckland-based medicine company, is launching its campaign at midday with Snowball Effect, to raise the final $500,000 (minimum investment $1000) needed to start a two-phase clinical trial for Citramel, which could help the 75,000 people worldwide with cystic fibrosis.

Read more